Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
暂无分享,去创建一个
M. Link | G. Boriani | J. Daubert | B. Maron | W. Shen | M. Stanton | S. Betocchi | N. Estes | S. Favale | G. Bardy | A. Epstein | R. Rea | A. Almquist | P. Spirito | S. Casey | Andrew E Epstein | W. Shen
[1] B. Maron,et al. Hypertrophic Cardiomyopathy Prognostic Value of Systemic Blood Pressure Response During Exercise in a Community-Based Patient Population With Hypertrophic Cardiomyopathy , 2016 .
[2] P. Elliott,et al. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.
[3] B. Maron,et al. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. , 1999, JAMA.
[4] B. Maron,et al. Aborted Sudden Cardiac Death in Hypertrophic Cardiomyopathy , 1999, Journal of cardiovascular electrophysiology.
[5] Paul J. Wang,et al. Clinical Profile of Commotio Cordis: An Under Appreciated Cause of Sudden Death in the Young During Sports and Other Activities , 1999, Journal of cardiovascular electrophysiology.
[6] C. Schuger,et al. Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses. , 1999, Journal of the American College of Cardiology.
[7] S. Hohnloser,et al. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. , 1998, Journal of the American College of Cardiology.
[8] R. Cappato,et al. Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators. , 1998, Journal of the American College of Cardiology.
[9] A. Moss,et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disea , 1998, Circulation.
[10] B. Maron,et al. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.
[11] M A Hlatky,et al. ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). , 1998, Circulation.
[12] G. Breithardt,et al. Is the implantable defibrillator indicated in patients with hypertrophic cardiomyopathy and aborted sudden death? , 1998, Journal of the American College of Cardiology.
[13] J. Brugada,et al. Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator. , 1998, Journal of the American College of Cardiology.
[14] A. Schaumann,et al. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. , 1998, Circulation.
[15] Huabin Sun,et al. The Value of Electrophysiology Study and Prophylactic Implantation of Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy , 1998, Pacing and clinical electrophysiology : PACE.
[16] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.
[17] W. Mckenna,et al. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. , 1997, Circulation.
[18] A. Moss,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.
[19] B. Maron,et al. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.
[20] W. Williams,et al. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.
[21] D. Zipes,et al. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. , 1995, Circulation.
[22] C. Autore,et al. Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia , 1994, Circulation.
[23] M. Silka,et al. Sudden Cardiac Death and the Use ofImplantable Cardioverter‐Defibrillators in Pediatric Patients , 1993, Circulation.
[24] W. Mckenna,et al. The management of hypertrophic cardiomyopathy. , 1997, The New England journal of medicine.
[25] A. Camm,et al. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. , 1989, Circulation.
[26] A. Castellanos,et al. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator. , 1989, Journal of the American College of Cardiology.
[27] B. Maron,et al. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. , 1989, Journal of the American College of Cardiology.
[28] K. Peterson,et al. Hypertrophic cardiomyopathy and sudden death. , 1988, The New England journal of medicine.
[29] W. Williams,et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.
[30] C. Oakley,et al. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. , 1985, British heart journal.
[31] J. Deanfield,et al. Hypertrophic cardiomyopathy: an important cause of sudden death. , 1984, Archives of disease in childhood.
[32] R. Bonow,et al. Hypertrophic cardiomyopathy. , 1987, Disease-a-month : DM.
[33] W. Mckenna,et al. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. , 1981, The American journal of cardiology.
[34] V L Gott,et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. , 1980, The New England journal of medicine.
[35] W. Roberts,et al. Quantitative Analysis of Cardiac Muscle Cell Disorganization in the Ventricular Septum of Patients with Hypertrophic Cardiomyopathy , 1979, Circulation.
[36] D. G. Ritter,et al. Idiopathic hypertrophic subaortic stenosis in the young. , 1978, The American journal of cardiology.
[37] W. Roberts,et al. Asymmetric Septal Hypertrophy in Childhood , 1976, Circulation.
[38] C. Oakley,et al. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. , 1974, Circulation research.
[39] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[40] D TEARE,et al. ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS , 1958, British heart journal.